MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$162,451K
EPS
-$1.87
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
157,697
General and administrative
21,001
Total operating expenses
178,698
Loss from operations
-178,698
Interest income
16,224
Other income
23
Total other income
16,247
Net loss
-162,451
Basic EPS
-1.87
Diluted EPS
-1.87
Basic Average Shares
87,006,027
Diluted Average Shares
87,006,027
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$16,224K Other income$23K Net loss-$162,451K Total other income$16,247K Loss from operations-$178,698K Total operatingexpenses$178,698K Research and development$157,697K General andadministrative$21,001K

Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals, Inc. (OLMA)